2HE Stock Chart & Stats
€84.00
€0.00(0.00%)
At close: 4:00 PM EDT
€84.00
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€61.00 - €91.50
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
€7.56B
Enterprise Value€7.69K
Total Cash (Recent Filing)€265.37M
Total Debt (Recent Filing)€984.68M
Price to Earnings (P/E)39.0
Beta0.46
Next Earnings
Aug 27, 2026EPS Estimate
1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding83,602,160
10 Day Avg. Volume12
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)3.50
Price to Sales (P/S)5.62
P/FCF Ratio16.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€97.74Price Target Upside16.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)4.05
Revenue Forecast (FY)€1.21B
Bulls Say, Bears Say
Bulls Say
HSA Asset Growth And Share GainsGrowing HSA accounts and assets expand HealthEquity’s recurring administration, custodial and payment revenue base. Outpacing market growth suggests competitive gains that can compound through employer relationships, member scale and higher balances.
Strong Profitability And Cash GenerationThe shift to sustained profitability alongside strong cash conversion supports reinvestment, acquisitions, debt reduction and shareholder returns. Free cash flow closely tracking net income also indicates earnings are supported by operating cash rather than weak-quality accruals.
Operating Leverage And Durable Efficiency GainsMargin expansion and automation can improve scalability as account volumes grow, allowing revenue to convert into profit more efficiently. AI-enabled service and fraud improvements may strengthen the platform’s cost structure if savings persist beyond initial implementation.
Bears Say
Exposure To HSA Cash Yields And Rate TimingCustodial income depends on cash yields, contract placement and market rates. Upcoming maturities create repricing risk, while hedges reduce but do not eliminate timing and spread uncertainty that could pressure revenue and margins over coming quarters.
Uncertainty Around Reported Leverage ChangeThe sharp debt movement makes the conservative TTM leverage profile difficult to assess without reconciliation. If the reduction is not fully durable, leverage and financing obligations could be higher than current metrics suggest, limiting financial flexibility.
Some Margin Gains May Not PersistPart of the recent cost improvement came from factors management described as seasonal or potentially temporary. Reversion in medical claims or fraud reimbursements could slow margin expansion and make future profitability less robust than the latest quarter implies.
Healthequity News
2HE FAQ
What was Healthequity’s price range in the past 12 months?
Healthequity lowest stock price was €61.00 and its highest was €91.50 in the past 12 months.
What is Healthequity’s market cap?
Healthequity’s market cap is €7.56B.
When is Healthequity’s upcoming earnings report date?
Healthequity’s upcoming earnings report date is Aug 27, 2026 which is tomorrow.
How were Healthequity’s earnings last quarter?
Healthequity released its earnings results on May 28, 2026. The company reported €1.063 earnings per share for the quarter, beating the consensus estimate of €0.955 by €0.107.
Is Healthequity overvalued?
According to Wall Street analysts Healthequity’s price is currently Undervalued.
Does Healthequity pay dividends?
Healthequity does not currently pay dividends.
What is Healthequity’s EPS estimate?
Healthequity’s EPS estimate is 1.02.
How many shares outstanding does Healthequity have?
Healthequity has 83,602,160 shares outstanding.
What happened to Healthequity’s price movement after its last earnings report?
Healthequity reported an EPS of €1.063 in its last earnings report, beating expectations of €0.955. Following the earnings report the stock price went up 4.73%.
Which hedge fund is a major shareholder of Healthequity?
Currently, no hedge funds are holding shares in DE:2HE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthequity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€97.74 (16.36% Upside)
€97.74 (16.36% Upside)
Blogger Sentiment
Bullish
DE:2HE Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.13%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.22%
Trailing 12-Months
Company Description
Healthequity
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
2HE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized solid execution: revenue and gross profit records, margin expansion, strong adjusted EBITDA growth (+17% YoY) and raised guidance, supported by healthy HSA account/asset growth, digital engagement gains, AI-driven service efficiencies, and an expanded $1B share repurchase authorization. Lowlights were mostly timing/one-time items (breakage fee, lower fraud reimbursements), early-stage marketplace revenue (not yet material), exposure in HSA cash maturities and interest-rate timing, and caution that some service-cost improvements may be seasonal or temporary. Overall, the positives around durable account/asset growth, margin expansion, cash generation and strategic initiatives materially outweigh the cautions and one-offs.View all DE:2HE earnings summaries2HE Revenue Breakdown
49.92% Service revenue
32.85% Custodial revenue
17.23% Interchange revenue
2HE Stock 12 Month Forecast
Average Price Target
€97.74
▲(16.36% Upside)
Technical Analysis
Omnicell
―
―
Doximity
―
BrightSpring Health Services, Inc.
―
Hinge Health, Inc. Class A
―